Inhibition of IFN-γ-induced Janus kinase-1-STAT1 activation in macrophages by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide

Journal of Immunology

Volumn 165, Issue 6, 2000, Pages 3051-3057

  Delgado, M ^a   Ganea, D ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; INTERLEUKIN 12; JANUS KINASE; NEUROPEPTIDE; NITRIC OXIDE SYNTHASE; PROTEIN P40; STAT PROTEIN; VASOACTIVE INTESTINAL POLYPEPTIDE ANTIBODY;

ANIMAL CELL; ARTICLE; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNOMODULATION; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SUPPRESSOR GENE; TRANSACTIVATION; WESTERN BLOTTING;

EID: 0034665081     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.6.3051     Document Type: Article

References (64)

1. Macrophages and inflammatory mediators in tissue injury
2. JAK-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling responses
3. Stat recruitment by tyrosine-phosphorylated cytokine receptors: An ordered reversible affinity-driven process
4. A novel interferon-inducible domain: Structural and functional analysis of the human IRF1 gene promoter
5. Tyrosine phosphorylated p91 binds to a single element in the ISGF2/IRF-1 promoter to mediate induction by IFN-α and IFN-γ, and is likely to autoregulate the p91 gene
6. Stimulation of the human intercellular adhesion molecule-1 promoter by IL-6 and IFN-γ involves binding of distinct factors to a palindromic response element
7. Selective interaction of a subset of IFN-γ response element-binding proteins with the intercellular adhesion molecule-1 (ICAM-1) gene promoter controls the pattern of expression on epithelial cells
8. The IL-12 p40 gene promoter is primed by interferon-γ in monocytic cells
9. Identification and characterization of a novel Ets-2-related nuclear complex implicated in the activation of human IL-12 p40 gene promoter
10. Synergistic regulation of the human IL-12 p40 promoter by NFkB and Ets transcription factors in Epstein-Barr virus-transformed B cells and macrophages
11. Macrophage nitric oxide synthase gene: Two upstream regions mediate induction by interferon-γ and lipopolysaccharide
12. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon-γ and bacterial lipopolysaccharide
13. Molecular cloning, structure, and chromosomal localization of the human inducible nitric oxide synthase gene
14. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages
15. Role of interferon regulatory factor 1 in induction of nitric oxide synthase
16. The significance of vasoactive intestinal peptide (VIP) in immunomodulation
17. VIP modulation of immune cell functions
18. Selectivity of effects of vasoactive intestinal peptide on macrophages and lymphocytes in compartmental immune responses
19. Regulatory effects of vasoactive intestinal peptide on cytokine production in central and peripheral lymphoid organs
20. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide modulate endotoxin-induced IL-6 production by murine peritoneal macrophages
21. Differential effects of gastrin-releasing peptide, neuropeptide Y, somatostatin, and vasoactive intestinal peptide on interleukin-1β, interleukin-6, and tumor necrosis factor-α production by whole blood cells from healthy young and old subjects
22. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-α production by macrophages: In vitro and in vivo studies
23. VIP and PACAP prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-κB and interferon regulatory factor I activation
24. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: In vitro and in vivo studies
25. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide protect mice from lethal endotoxemia through the inhibition of TNF-α and IL-6
26. Glutamate toxicity in the lung and neuronal cells: Prevention or attenuation by VIP and PACAP
27. Molecules that protect: The defense of neurons and other cells
28. Vasoactive intestinal peptide and nitric oxide: Divergent roles in relation with tissue injury
29. 25-1553 inhibits the production of TNF and IL-12 by LPS-activated monocytes
30. Vasoactive intestinal peptide inhibits IL-12 and nitric oxide production in murine macrophages
31. VIP and PACAP inhibit IL-12 production in LPS-stimulated macrophages. Subsequent effect on IFN-γ synthesis by T cells
32. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit TNFα transcriptional activation by regulating NF-κB and CREB/c-Jun
33. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit interleukin-12 transcription by regulating nuclear factor-κB and Ets activation
34. Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-β gene regulatory elements
35. Twenty proteins containing a C-terminal SOCS box form five structural classes
36. Rapid detection of octamer binding proteins with 'mini-extracts' prepared from a small number of cells
37. Analysis of the IFN-γ-signaling pathway in macrophages at different stages of maturation
38. Transcriptional responses to polypeptide ligands: The JAK-STAT pathway
39. Protein tyrosine phosphorylation as a mechanism which regulates cytokine activation of early response genes
40. In vitro properties of a high affinity selective antagonist of the VIP1 receptor
41. Fragments of the pituitary adenylate cyclase-activating polypeptide discriminate between type I and II recombinant receptors
42. The suppressor of cytokine signaling (SOCS)1 and SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities
43. Lipopolysaccharide induces in macrophages the synthesis of the suppressor of cytokine signaling 3 and suppresses signal transduction in response to the activating factor IFN-γ
44. Expression of vasoactive intestinal peptide in lymphocytes: A possible endogenous role in the regulation of the immune system
45. Proinflammatory and immunoregulatory functions of IL-12
46. Nitric oxide and macrophage function
47. Interleukin 6: An overview
48. The pathophysiology of tumor necrosis factor
49. The Janus protein tyrosine kinase family and its role in cytokine signaling
50. Interleukin-4 mediated inhibition of nitric oxide production in interferon-γ-treated and virus-infected macrophages
51. Nomenclature of receptors for vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP)
52. Characterization of gene expression of VIP and VIP1-receptor in rat peritoneal lymphocytes and macrophages
53. Functional characterization and mRNA expression of pituitary adenylate cyclase-activating polypeptide (PACAP) type I receptor in rat peritoneal macrophages
54. Inhibition of transcription factor Stat1 activity in mononuclear cell cultures and T cells by the cyclic AMP signaling pathway
55. Inhibition of cytokines and JAK-STAT activation by distinct signaling pathways
56. Regulation by cAMP of STAT1 activation in hepatic stellate cells
57. Protein kinase A-mediated inhibition of interferon-γ-induced tyrosine phosphorylation of Janus kinases and latent cytoplasmic transcription factors in human monocytes by Ehrlichia chaffeensis
58. Inhibitors keep cytokines in check
59. The CIS/SOCS proteins: A family of cytokine-inducible regulators of signaling
60. The SOCS-1 story
61. Expression of functional prolactin receptors in nonpregnant human endometrium: Janus kinase-2, signal transducer and activator of STAT1 and STAT5 proteins are phosphorylated after stimulation with prolactin
62. Ethanol inhibits prolactin-induced activation of the Jak/STAT pathway in cultured astrocytes
63. Participation of JAK and STAT proteins in growth hormone-induced signaling
64. Binding of α-melanocyte-stimulating hormone to its G-protein coupled receptor on B lymphocytes activates the Jak/STAT pathway